Back to top
more

Teleflex (TFX)

(Delayed Data from NYSE)

$241.53 USD

241.53
250,708

+0.09 (0.04%)

Updated Sep 18, 2024 04:00 PM ET

After-Market: $241.38 -0.15 (-0.06%) 7:56 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value F Growth B Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 25% (62 out of 250)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Veracyte (VCYT) Up 9.2% Since Last Earnings Report: Can It Continue?

by Zacks Equity Research

Veracyte (VCYT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

TFX or PEN: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

TFX vs. PEN: Which Stock Is the Better Value Option?

Teleflex's (TFX) Titan SGS Stapler Showcases Positive Outcomes

by Zacks Equity Research

Teleflex (TFX) publishes an analysis of clinical data showcasing the Titan SGS Stapler's enhanced clinical outcomes and significant efficiency benefits.

TFX or EW: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

TFX vs. EW: Which Stock Is the Better Value Option?

Align Technology (ALGN) Encounters Low ASP, FX Headwinds

by Zacks Equity Research

Align Technology's (ALGN) Clear Aligner ASP is facing a significant impact of unfavorable foreign exchange across multiple currencies.

Is Phibro (PAHC) Stock Worth Retaining in Your Portfolio Now?

by Zacks Equity Research

Phibro's (PAHC) Animal Health business, supported by the flourishing Vaccine product line, drives optimism for future growth. However, macroeconomic impacts are a concern.

TFX or EW: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

TFX vs. EW: Which Stock Is the Better Value Option?

Why Teleflex (TFX) is a Top Growth Stock for the Long-Term

by Zacks Equity Research

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Teleflex (TFX) Tops Q2 Earnings Estimates, Raises 2024 Outlook

by Zacks Equity Research

Teleflex's (TFX) diversified portfolio and global footprint have driven durable growth in the second quarter of 2024.

Compared to Estimates, Teleflex (TFX) Q2 Earnings: A Look at Key Metrics

by Zacks Equity Research

While the top- and bottom-line numbers for Teleflex (TFX) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Teleflex (TFX) Q2 Earnings Surpass Estimates

by Zacks Equity Research

Teleflex (TFX) delivered earnings and revenue surprises of 2.70% and 1.79%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Urmimala Biswas headshot

What's in Store for These 4 MedTech Stocks in Q2 Earnings?

by Urmimala Biswas

Here is a sneak peek into how four MedTech companies, LH, BIO, TFX and BRKR, are expected to fare in their second-quarter results, slated to be released tomorrow.

What Analyst Projections for Key Metrics Reveal About Teleflex (TFX) Q2 Earnings

by Zacks Equity Research

Get a deeper insight into the potential performance of Teleflex (TFX) for the quarter ended June 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.

Earnings Preview: 908 Devices Inc. (MASS) Q2 Earnings Expected to Decline

by Zacks Equity Research

908 Devices (MASS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Earnings Preview: Teleflex (TFX) Q2 Earnings Expected to Decline

by Zacks Equity Research

Teleflex (TFX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

What Makes Teleflex (TFX) a New Buy Stock

by Zacks Equity Research

Teleflex (TFX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

TFX vs. SONVY: Which Stock Is the Better Value Option?

by Zacks Equity Research

TFX vs. SONVY: Which Stock Is the Better Value Option?

Is it Wise to Hold Teleflex (TFX) Stock in Your Portfolio Now?

by Zacks Equity Research

Teleflex (TFX) holds strong momentum in the Interventional arm and a favorable solvency. Yet, macroeconomic impacts and competitive environment trigger concerns.

Glaukos (GKOS) Stock Jumps 3.7%: Will It Continue to Soar?

by Zacks Equity Research

Glaukos (GKOS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

by Zacks Equity Research

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Why This 1 Value Stock Could Be a Great Addition to Your Portfolio

by Zacks Equity Research

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio

by Zacks Equity Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Teleflex's (TFX) Urolift Drives Market Share, Macro Woes Stay

by Zacks Equity Research

The commercialization of Teleflex's (TFX) UroLift in Japan has been a significant step toward making this therapy more broadly available to men suffering from BPH.

Here's Why Teleflex (TFX) is a Strong Value Stock

by Zacks Equity Research

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Why Teleflex (TFX) is a Top Momentum Stock for the Long-Term

by Zacks Equity Research

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.